[artículo]
Título : |
Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials |
Tipo de documento: |
texto impreso |
Autores: |
Stephen M. Stahl, Autor ; Joseph Mendels, Autor ; Gerri E. Schwartz, Autor |
Fecha de publicación: |
2023 |
Artículo en la página: |
pp. 388-392 |
Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
Palabras clave: |
Antidepresivos, Ansiedad, Trastorno depresivo mayor, Morfolinas, Agitación psicomotora, Ensayos controlados aleatorios, Trastornos de inicio y mantenimiento del sueño. |
Resumen: |
Several recent clinical trials have established that reboxetine, a new selective norepinephrine reuptake inhibitor (selective NRI), is effective and safe for the treatment of major depression. However, the effects of reboxetine on specific symptoms of anxiety, agitation, and insomnia have not been reported. |
Link: |
./index.php?lvl=notice_display&id=31055 |
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 388-392
[artículo] Effects of reboxetine on anxiety, agitation, and insomnia: results of a pooled evaluation of randomized clinical trials [texto impreso] / Stephen M. Stahl, Autor ; Joseph Mendels, Autor ; Gerri E. Schwartz, Autor . - 2023 . - pp. 388-392. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 4 (Agosto) . - pp. 388-392
Palabras clave: |
Antidepresivos, Ansiedad, Trastorno depresivo mayor, Morfolinas, Agitación psicomotora, Ensayos controlados aleatorios, Trastornos de inicio y mantenimiento del sueño. |
Resumen: |
Several recent clinical trials have established that reboxetine, a new selective norepinephrine reuptake inhibitor (selective NRI), is effective and safe for the treatment of major depression. However, the effects of reboxetine on specific symptoms of anxiety, agitation, and insomnia have not been reported. |
Link: |
./index.php?lvl=notice_display&id=31055 |
|